Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vascular Access and Intraosseus

NCT: NCT07471555 · ENROLLING_BY_INVITATION

NCT IDNCT07471555
StatusENROLLING_BY_INVITATION
Start Date2026-04-02
Completion2026-12-03

Brief Summary

Rapid administration of epinephrine is an essential component of advanced life support during cardiac arrest. Peripheral intravenous (IV) access is commonly used for drug delivery, while intraosseous (IO) access is an alternative when IV access is not readily available. In addition, epinephrine may be administered using different drug presentations, such as ampoules or prefilled syringes, which may influence procedural workflow during resuscitation.

Frequently Asked Questions

What is Vascular Access and Intraosseus?

Vascular Access and Intraosseus is a clinical trial registered under NCT07471555. Current status: ENROLLING_BY_INVITATION.

What is the status of NCT07471555?

The current status of NCT07471555 (Vascular Access and Intraosseus) is: ENROLLING_BY_INVITATION.

When did Vascular Access and Intraosseus start?

Vascular Access and Intraosseus started on 2026-04-02.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.